Trial Profile
Immunogenicity and Safety of Meningococcal (A, C, Y and W135) Conjugate Vaccine in Healthy Subjects 2 Months to 6 Years of Age in China
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 24 Sep 2015
Price :
$35
*
At a glance
- Drugs Meningococcal vaccine groups A-C-Y-W-135 conjugate-Minhai (Primary) ; Hib vaccine conjugate; Meningococcal vaccine group A polysaccharide; Meningococcal vaccine groups A and C conjugate; Meningococcal vaccine groups A C Y W-135 polysaccharide
- Indications Haemophilus infections; Meningococcal group A infections; Meningococcal group C infections; Meningococcal group W-135 infections; Meningococcal group Y infections
- Focus Pharmacodynamics; Registrational
- Sponsors Beijing Minhai Biotechnology
- 21 Sep 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
- 14 Dec 2013 New trial record